A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 2, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Cancer, Chronic Lymphocytic Leukemia (CLL)
Trial Locations (13)

16499

RECRUITING

Ajou University Hospital /ID# 249512, Suwon

41944

RECRUITING

Kyungpook National University Hospital /ID# 233884, Junggu

47392

RECRUITING

Inje University - Busan Paik Hospital /ID# 233882, Busan

49241

RECRUITING

Pusan National University Hospital /ID# 216850, Busan

58128

RECRUITING

Chonnam National University Hwasun Hospital /ID# 216849, Hwasun-gun

03300

RECRUITING

The catholic university of korea st. Paul's hospital /ID# 238907, Seoul

02841

RECRUITING

Korea University Anam Hospital /ID# 216851, Seoul

03080

RECRUITING

Seoul National University Hospital /ID# 216853, Seoul

06351

RECRUITING

Samsung Medical Center /ID# 217180, Seoul

06591

COMPLETED

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 216852, Seoul

RECRUITING

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 217181, Seoul

07345

RECRUITING

The Catholic University of Korea, Yeouido ST. Mary's Hospital /ID# 217179, Seoul

03722

RECRUITING

Yonsei University Health System Severance Hospital /ID# 215348, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY